THQ
Fiscal year ends September Quarters are offset from the calendar — Q1 is Oct–Dec

abrdn Healthcare Opportunities Fund is a closed-end management investment company that seeks current income and long-term capital appreciation. The Fund invests the majority of its managed assets in U.S. and non-U.S. companies engaged in the healthcare industry, including equity securities, debt securities, and pooled investment vehicles. It defines a Healthcare Company as one where a significant portion of sales, earnings, or assets arise from healthcare products, services, or medical technology activities. The Fund's portfolio includes sub-sectors such as pharmaceuticals, biotechnology, managed care, life science tools, healthcare technology, healthcare services, healthcare supplies, healthcare facilities, healthcare equipment, healthcare distributors, and Healthcare REITs. The Fund invests primarily in equity securities, including common stock, preferred stock, and convertible securities. It may invest in debt securities, including non-investment grade or high yield securities. The Fund employs a strategy of writing covered call and put options to generate current income. It may invest in non-U.S. securities, including emerging market issuers, and in restricted securities. The Fund may invest in real estate investment funds deriving income from healthcare sector properties.

Summarised from the fund's shareholder report or prospectus, filed Dec 2025

Industry Asset Management Homepage teklacap.com
Sector Financial Services IR page —
Tags
closed-end fund, healthcare, biotechnology, pharmaceuticals, managed care, healthcare technology, healthcare equipment, healthcare reits, high yield debt, options writing, emerging markets, abrdn Healthcare Opportunities Fund
Press page —

Metrics

Valuation  
Market cap $ 762.45M
Market cap (USD) $ 762.45M
P/E -26.29
PEG —
P/BV 1.06
P/S 35.57
Discount/premium to NAV -3.4%
P/OCF 8.63
P/FCF 8.63
Dividend yield 11.7%
Turnover / mcap —
Returns  
ROE -13.6%
ROI -11.9%
ROIC -0.22%
Profit margin -535.8%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score -26.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue 21.434M 23.742M 54.684M -84.151M 196.542M —
Net profit -114.844M 189.562M 52.786M -86.252M 194.653M —
Free cash flow 88.376M 78.263M 55.813M 55.556M 33.074M —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Share price 17.29 22.08 — — — 18.09
Price performance 12m -0.22 0.3 — — — 0.04

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

abrdn Healthcare Opportunities Fund Shares of Beneficial Interest (ticker THQ), listed in United States.

Company History

Date Change Detail
Nov 6, 2023 Renamed Tekla Healthcare Opportunities Fund → abrdn Healthcare Opportunities Fund
Jun 9, 2014 Renamed Tekla Healthcare Growth & Income Fund → Tekla Healthcare Opportunities Fund

ETFs Holding abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

ETF Weight in ETF Shares Market value As of
FCEF 2.30% 95,432 $ 1.803M Nov 16, 2026